Erik H.F. Wong

9.1k total citations · 1 hit paper
91 papers, 6.9k citations indexed

About

Erik H.F. Wong is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Erik H.F. Wong has authored 91 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cellular and Molecular Neuroscience, 63 papers in Molecular Biology and 16 papers in Organic Chemistry. Recurrent topics in Erik H.F. Wong's work include Neuroscience and Neuropharmacology Research (45 papers), Neurotransmitter Receptor Influence on Behavior (32 papers) and Receptor Mechanisms and Signaling (31 papers). Erik H.F. Wong is often cited by papers focused on Neuroscience and Neuropharmacology Research (45 papers), Neurotransmitter Receptor Influence on Behavior (32 papers) and Receptor Mechanisms and Signaling (31 papers). Erik H.F. Wong collaborates with scholars based in United States, United Kingdom and Poland. Erik H.F. Wong's co-authors include Alan C. Foster, J A Kemp, G.N. Woodruff, A.R. Knight, L L Iversen, Tony Priestley, Richard M. Eglen, John A. Kemp, Geoffrey N. Woodruff and Antony R. Knight and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Erik H.F. Wong

91 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

1986 1.5k citations Erik H.F. Wong, G.N. Woodruff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik H.F. Wong United States	40	4.9k	3.7k	857	719	673	91	6.9k
Maarten E. A. Reith United States	50	6.1k 1.3×	4.8k 1.3×	638 0.7×	576 0.8×	737 1.1×	241	8.7k
David Bleakman United States	45	4.8k 1.0×	3.5k 0.9×	1.1k 1.3×	354 0.5×	476 0.7×	94	6.5k
H. Gozlan France	47	6.5k 1.3×	4.1k 1.1×	1.1k 1.3×	563 0.8×	682 1.0×	120	8.2k
Ben H.C. Westerink Netherlands	56	6.3k 1.3×	3.6k 1.0×	1.3k 1.5×	726 1.0×	905 1.3×	180	9.1k
S.J. Enna United States	58	6.8k 1.4×	4.7k 1.3×	986 1.2×	819 1.1×	935 1.4×	170	10.1k
Derek N. Middlemiss United Kingdom	53	7.5k 1.5×	5.6k 1.5×	1.0k 1.2×	947 1.3×	947 1.4×	137	10.7k
John A. Kemp United States	55	6.7k 1.4×	5.0k 1.4×	1.9k 2.2×	447 0.6×	559 0.8×	126	9.3k
David R. Burt United States	33	6.5k 1.3×	4.8k 1.3×	771 0.9×	1.2k 1.6×	439 0.7×	91	9.0k
Mark D. Tricklebank United Kingdom	46	4.3k 0.9×	2.4k 0.7×	1.5k 1.7×	588 0.8×	646 1.0×	125	6.3k
Maharaj K. Ticku United States	53	6.6k 1.4×	3.9k 1.0×	1.3k 1.5×	703 1.0×	344 0.5×	188	8.6k

Countries citing papers authored by Erik H.F. Wong

Since Specialization

Citations

This map shows the geographic impact of Erik H.F. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik H.F. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik H.F. Wong more than expected).

Fields of papers citing papers by Erik H.F. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik H.F. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik H.F. Wong. The network helps show where Erik H.F. Wong may publish in the future.

Co-authorship network of co-authors of Erik H.F. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Erik H.F. Wong. A scholar is included among the top collaborators of Erik H.F. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik H.F. Wong. Erik H.F. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, Allyson K., Barbara Juarez, Stacy M. Ku, et al.. (2016). KCNQ channel openers reverse depressive symptoms via an active resilience mechanism. Nature. 35 indexed citations

Wong, Erik H.F., Frank D. Yocca, Mark A. Smith, & Chi‐Ming Lee. (2010). Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. The International Journal of Neuropsychopharmacology. 13(9). 1269–1284. 74 indexed citations

Marston, Hugh, Jared W. Young, Kevin A. Serpa, et al.. (2009). Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology. 206(4). 699–714. 42 indexed citations

Huang, Mei, Zhu Li, Jin Dai, et al.. (2008). Asenapine Increases Dopamine, Norepinephrine, and Acetylcholine Efflux in the Rat Medial Prefrontal Cortex and Hippocampus. Neuropsychopharmacology. 33(12). 2934–2945. 49 indexed citations

Tarazi, Frank I., Taylor Moran‐Gates, Erik H.F. Wong, Brian Henry, & Mohammed Shahid. (2008). Differential regional and dose-related effects of asenapine on dopamine receptor subtypes. Psychopharmacology. 198(1). 103–111. 34 indexed citations

Hajós, Mihály, et al.. (2004). The Selective Norepinephrine Reuptake Inhibitor Antidepressant Reboxetine: Pharmacological and Clinical Profile. CNS Drug Reviews. 10(1). 23–44. 175 indexed citations

Wong, Erik H.F., Mark S. Sonders, Susan Amara, et al.. (2000). Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biological Psychiatry. 47(9). 818–829. 291 indexed citations

Bonhaus, Douglas W., Joel G. Berger, Nika Adham, et al.. (1997). [ 3 H]RS 57639, a High Affinity, Selective 5-HT 4 Receptor Partial Agonist, Specifically Labels Guinea-pig Striatal and Rat Cloned (5-HT 4S and 5-HT 4L ) Receptors. Neuropharmacology. 36(4-5). 671–679. 8 indexed citations

Terry, Alvin V., Jerry J. Buccafusco, Mark Prendergast, et al.. (1996). The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. Neuroreport. 8(1). 49–54. 13 indexed citations

10.

Fontana, D., Scott E. Daniels, C. A. Henderson, Richard M. Eglen, & Erik H.F. Wong. (1995). Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology. 120(4). 409–417. 51 indexed citations

11.

Wong, Erik H.F., et al.. (1995). Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behavioural Brain Research. 73(1-2). 249–252. 60 indexed citations

12.

Eglen, Richard M., et al.. (1994). Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse. Neuropharmacology. 33(2). 227–234. 13 indexed citations

13.

Eglen, Richard M., Douglas W. Bonhaus, Robin D. Clark, et al.. (1994). (R) and (S) RS 56532: Mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity. Neuropharmacology. 33(3-4). 515–526. 16 indexed citations

14.

Ebert, Bjarke, Erik H.F. Wong, & Povl Krogsgaard‐Larsen. (1991). Identification of a novel NMDA receptor in rat cerebellum. European Journal of Pharmacology Molecular Pharmacology. 208(1). 49–52. 66 indexed citations

15.

Leeson, Paul D., Robert W. Carling, Kim James, et al.. (1990). Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel. Journal of Medicinal Chemistry. 33(5). 1296–1305. 21 indexed citations

16.

McKernan, Ruth M., Sandra C. de Castro, Judith A. Poat, & Erik H.F. Wong. (1989). Solubilization of the N‐Methyl‐d‐Aspartate Receptor Channel Complex from Rat and Porcine Brain. Journal of Neurochemistry. 52(3). 777–785. 62 indexed citations

17.

Bowery, Norman G., Erik H.F. Wong, & Alan L. Hudson. (1988). Quantitative autoradiography of [³H]‐MK‐801 binding sites in mammalian brain. British Journal of Pharmacology. 93(4). 944–954. 153 indexed citations

18.

Wong, Erik H.F., Anthony Knight, & Richard W. Ransom. (1987). Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain. European Journal of Pharmacology. 142(3). 487–488. 155 indexed citations

19.

Kemp, John A., Garland R. Marshall, Erik H.F. Wong, & G.N. Woodruff. (1987). The affinities, potencies and efficacies of some benzodiazepine‐receptor agonists, antagonists and inverse‐agonists at rat hippocampal GABA_A‐receptors. British Journal of Pharmacology. 91(3). 601–608. 49 indexed citations

20.

Singh, Lakhbir, et al.. (1987). A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine. European Journal of Pharmacology. 141(3). 497–501. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact